Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 11Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Breast Neoplasms 12Colorectal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Prostatic Neoplasms 5Lung Neoplasms 4Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3Leukemia, Megakaryoblastic, Acute 3Fallopian Tube Neoplasms 3Stomach Neoplasms 2Ovarian Neoplasms 2Obesity 2Neoplasms 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Hodgkin Disease 2Congenital Abnormalities 2Colonic Neoplasms 2Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Thymus Neoplasms 1Thymoma 1Sezary Syndrome 1Sertoli-Leydig Cell Tumor 1Salivary Gland Neoplasms 1

Interventions

Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Has results × Diabetes Mellitus, Type 2 × Clear all
NCT00038727 2021-12-28

DPPOS

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 3 Unknown
2,779 enrolled 16 charts
Other

Diabetes Mellitus, Diabetes Mellitus, Type 2, Neoplasms, Obesity, Prediabetic State

Data powered by HemOnc (CC BY 4.0) Colophon âš¡